Benzodiazepine Immunoassay Reagent Kits
Inactive
Contract Opportunity
Notice ID
N6264523R0009
Department/Ind. Agency
DEPT OF DEFENSE
Sub-tier
DEPT OF THE NAVY
Major Command
NAVSUP
Sub Command
NAVSUP OTHER HCA
Sub Command 2
BUMED
Sub Command 3
NAVY MEDICINE SUPPORT COMMAND
Office
NAVAL MEDICAL LOGISTICS COMMAND
Looking for contract opportunity help?
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
General Information
- Contract Opportunity Type: Solicitation (Updated)
- Updated Published Date: Dec 14, 2022 02:38 pm EST
- Original Published Date: Nov 22, 2022 03:29 pm EST
- Updated Date Offers Due: Dec 29, 2022 02:00 pm EST
- Original Date Offers Due: Dec 22, 2022 02:00 pm EST
- Inactive Policy: Manual
- Updated Inactive Date: Dec 30, 2022
- Original Inactive Date: Dec 30, 2022
- Initiative:
- None
Classification
- Original Set Aside:
- Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- NAICS Code:
- 334516 - Analytical Laboratory Instrument Manufacturing
- Place of Performance:
Description
The Department of Defense (DoD) Drug Demand Reduction Program (DDRP) has a requirement for Benzodiazepine Immunoassay reagent kits. The requirement is for a cost per test contract for Benzodiazepine Immunoassay reagents for six (6) DDRP laboratory found (OPI Reagent List of Requiring Activities).Immunoassay test reagent for the initial screen and the detection of nordiazepam, oxazepam, temazepam, lorazepam, and alpha-hydroxyalprazolam (benzodiazepines) in urine to include a �-glucuronidase enzymatic hydrolysis procedure in urine when present at a concentration equal to or greater than 200 ng/mL. The reagent shall not impose additional maintenance, servicing, or calibration requirements for the optimum performance of the contractor?s reagent on the Beckman Coulter AU5800 Series Clinical Chemistry Analyzers. Immunoassay kits shall have clearance from the FDA in order to meet the requirements of DODI 1010.16 Rev (June 15, 2020). Amendment 0002 was created to reflect changes to the Statement of Work and update FAR 52.212-1 Addendum and FAR 52.212-2 Evaluation Factor A. *Visit 'https://piee.eb.mil/sol/xhtml/unauth/search/oppMgmtLink.xhtml?solNo=N6264523R0009' to obtain more details.*
Attachments/Links
Contact Information
Contracting Office Address
- 693 NEIMAN STREET
- FORT DETRICK , MD 21702-9203
- USA
Primary Point of Contact
- Curtis Cardoza
- curtis.e.cardoza.civ@health.mil
- Phone Number 301-619-3020
Secondary Point of Contact
History
- Dec 30, 2022 11:56 pm ESTSolicitation (Updated)
- Dec 01, 2022 10:59 am ESTSolicitation (Updated)
- Nov 29, 2022 12:38 pm ESTSolicitation (Updated)
- Nov 22, 2022 03:29 pm ESTSolicitation (Original)